117 related articles for article (PubMed ID: 228313)
21. Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin.
Ohara N; Ono H; Hashimoto K
Jpn Circ J; 1981 Jun; 45(6):672-9. PubMed ID: 6165844
[TBL] [Abstract][Full Text] [Related]
22. Beneficial action of new angiotensin-converting enzyme inhibitor (SQ 14,225) in hemorrhagic shock in cats.
Trachte GJ; Lefer AM
Circ Res; 1978 Oct; 43(4):576-82. PubMed ID: 210975
[No Abstract] [Full Text] [Related]
23. Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity.
Lindsey CJ; Bendhack LM; Paiva AC
J Hypertens Suppl; 1987 Jul; 5(2):S71-6. PubMed ID: 2821209
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
Persson K; Andersson RG
Eur J Pharmacol; 1999 Nov; 385(1):21-7. PubMed ID: 10594341
[TBL] [Abstract][Full Text] [Related]
25. Effect of the angiotensin-converting enzyme inhibitor, captopril, on development of renal hypertension in rats.
Fregly MJ; Lockley OE; Simpson CE
Pharmacology; 1981; 22(5):277-85. PubMed ID: 7019935
[No Abstract] [Full Text] [Related]
26. Potentiation of the algogenic action of bradykinin by an inhibitor of angiotensin I converting enzyme, captopril (SQ 14,225).
Nakano T; Taira N
Jpn J Pharmacol; 1979 Aug; 29(4):563-71. PubMed ID: 231702
[No Abstract] [Full Text] [Related]
27. [Pharmacological effects of captopril].
Rubin B; Antonaccio J
Nouv Presse Med; 1981 Apr; 10(19):1531-46. PubMed ID: 6269555
[No Abstract] [Full Text] [Related]
28. Effect of angiotensin-converting enzyme inhibition by captopril on cardiac output, coronary blood flow, and systemic arterial blood pressure in the intact and in the bilaterally nephrectomized rabbit.
Ohmae M; Rabkin SW; Fung HY
J Cardiovasc Pharmacol; 1981; 3(5):1060-7. PubMed ID: 6168851
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
Gubert S; Braso MA; Sacristán A; Ortiz JA
Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
[TBL] [Abstract][Full Text] [Related]
30. Effect of intracoronary captopril on coronary blood flow and regional myocardial function in dogs.
Noguchi K; Kato T; Ito H; Aniya Y; Sakanashi M
Eur J Pharmacol; 1985 Mar; 110(1):11-9. PubMed ID: 3891380
[TBL] [Abstract][Full Text] [Related]
31. [Inhibition of angioten converting enzyme by phosphryl derivatives in rats (author's transl)].
Mikami H; Ogihara T; Morikawa T; Sakakibara S; Kumahara Y
Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1443-8. PubMed ID: 6278180
[No Abstract] [Full Text] [Related]
32. Reversal by acetylsalicylic acid of the captopril-induced inhibition of angiotensin converting enzyme in the hindquarters of guinea-pig.
Melli M; Türker RK
Arch Int Pharmacodyn Ther; 1982 May; 257(1):87-93. PubMed ID: 6287951
[TBL] [Abstract][Full Text] [Related]
33. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
Matthews PG; McGrath BP; Johnston CI
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of angiotensin-converting enzyme.
Cushman DW; Ondetti MA; Cheung HS; Antonaccio MJ; Murthy VS; Rubin B
Adv Exp Med Biol; 1980; 130():199-225. PubMed ID: 6250340
[No Abstract] [Full Text] [Related]
35. Comparison of the time course of action of captopril on angiotensin-converting enzyme with the time course of its antihypertensive effect.
Velletri P; Bean BL
J Cardiovasc Pharmacol; 1981; 3(5):1068-81. PubMed ID: 6168852
[TBL] [Abstract][Full Text] [Related]
36. Renal, adrenal and vascular changes during inhibition of converting enzyme with captopril.
Clappison BH; Millar JA; Casley DJ; Anderson WP; Johnston CI
Clin Exp Pharmacol Physiol; 1980; 7(5):493-8. PubMed ID: 6256104
[TBL] [Abstract][Full Text] [Related]
37. The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme.
Morton JJ; Tree M; Casals-Stenzel J
Clin Sci (Lond); 1980 Jun; 58(6):445-50. PubMed ID: 6253115
[TBL] [Abstract][Full Text] [Related]
38. Dependence of renal vasodilator effect of captopril on prevailing plasma renin level in the dog: influence of DOCA-salt treatment.
Wong PC; Zimmerman BG
Clin Sci (Lond); 1982 Oct; 63(4):355-60. PubMed ID: 7049508
[TBL] [Abstract][Full Text] [Related]
39. Feline hypoxic pulmonary vasoconstriction is not blocked by the angiotensin I-converting enzyme inhibitor, captopril.
Prewitt RL; Leffler CW
J Cardiovasc Pharmacol; 1981; 3(2):293-8. PubMed ID: 6166801
[TBL] [Abstract][Full Text] [Related]
40. Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response.
Boomsma F; de Bruyn JH; Derkx FH; Schalekamp MA
Clin Sci (Lond); 1981 May; 60(5):491-8. PubMed ID: 6265138
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
